行情

ELGX

ELGX

恩多勒吉克斯
NASDAQ

实时行情|Nasdaq Last Sale

0.6151
-0.0529
-7.92%
已收盘, 19:44 04/03 EDT
开盘
0.7000
昨收
0.6680
最高
0.7053
最低
0.6000
成交量
16.25万
成交额
--
52周最高
8.14
52周最低
0.6000
市值
1,174.37万
市盈率(TTM)
-0.1391
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ELGX价格均价为3.600,最高价位7.00,最低价为1.000。

EPS

ELGX 新闻

更多
  • Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Business Wire · 6天前
  • Endologix Earlier Adds Jane E. Kiernan To Its Board Of Directors
  • Benzinga · 03/18 13:26
  • Endologix Adds Jane E. Kiernan to its Board of Directors
  • Business Wire · 03/17 23:30
  • FDA OKs Endologix next-generation endograft
  • seekingalpha · 03/16 18:55

所属板块

医疗设备、用品及经销
-0.92%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

ELGX 简况

Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.
展开

微牛提供Endologix, Inc.(NASDAQ-ELGX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ELGX股票新闻,以帮助您做出投资决策。